11 Guideline Recommendations in CML

CML AK Book

Preface
1 Introduction
2 TKIs for CML
3 Dasatinib
4 Asciminib
5 ELVN-001
6 TERN-701 CARDINAL Phase 1 Study Analysis
7 TGRX-678 Phase 1 Study Analysis: Efficacy in CML Patients with T315I Mutation
8 Olverembatinib
9 Additional Mutations in CML
10 BCR-ABL1 TKD mutations
11 Guideline Recommendations in CML
12 TKI Discontinuation
13 HSCT for CML
14 Summary
References

Table of contents

11.1 ELN recommendations for the diagnosis and treatment of CML (Cross et al. 2023)

11 Guideline Recommendations in CML

11.1 ELN recommendations for the diagnosis and treatment of CML (Cross et al. 2023)

Cross, Nicholas C. P., Thomas Ernst, Susan Branford, et al. 2023. “European LeukemiaNet Laboratory Recommendations for the Diagnosis and Management of Chronic Myeloid Leukemia.” Leukemia 37 (11): 2150–67. https://doi.org/10.1038/s41375-023-02048-y.

10 BCR-ABL1 TKD mutations

12 TKI Discontinuation